Literature DB >> 10837472

Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.

Y Yang1, K Janota, K Tabei, N Huang, M M Siegel, Y I Lin, B A Rasmussen, D M Shlaes.   

Abstract

The reactions of class A beta-lactamases PC1 and TEM-1 with tazobactam (TZB), a potent penicillanic sulfone inhibitor for class A beta-lactamases, were studied using electrospray ionization mass spectrometry (ESI/MS). Following inactivation of the beta-lactamases by TZB, new abundant high mass components were observed including three with molecular masses of 52, 70, and 88 Da greater than PC1 and TEM-1, respectively, and a component with a molecular mass of 300 Da greater than PC1. In addition, three TZB reaction products with molecular masses of 248, 264, and 280 Da were observed. High performance liquid chromatography (HPLC)/ESI/MS analysis of the TZB-PC1 adduct digested with Glu-C revealed three new components with masses 52, 70, and 88 Da greater than that of the peptide composed of amino acid residues 58-82 and one new component with a mass 70 Da greater than that of the peptide composed of amino acid residues 125-141. HPLC/ESI/MS/MS analysis of the two digested peptides whose masses increased by 70 Da indicated that Ser-70 and Ser-130 were the most likely TZB-modified amino acid residues. Based on these data, a mechanism for the inactivation of the class A beta-lactamases by TZB is proposed. In this scheme, initial acylation of Ser-70 by TZB and opening of the lactam ring are followed by one of several different events: (1) the rapid decomposition of TZB with loss of the enamine moiety to form the propiolylated enzyme, (2) an intramolecular nucleophilic displacement of the imine or enamine moiety by Ser-130 to form a cross-linked vinyl ether, and (3) hydrolysis of the imine or enamines to form a Ser-70-linked aldehyde.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837472     DOI: 10.1074/jbc.M002369200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Influence of substrates and inhibitors on the structure of Klebsiella pneumoniae carbapenemase-2.

Authors:  Ben A Shurina; Richard C Page
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-04

2.  Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.

Authors:  Pius S Padayatti; Anjaneyulu Sheri; Monica A Totir; Marion S Helfand; Marianne P Carey; Vernon E Anderson; Paul R Carey; Christopher R Bethel; Robert A Bonomo; John D Buynak; Focco van den Akker
Journal:  J Am Chem Soc       Date:  2006-10-11       Impact factor: 15.419

3.  Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry.

Authors:  Hilary Frase; Clyde A Smith; Marta Toth; Matthew M Champion; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

4.  Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Jocelyne Caillon; Melissa D Barnes; Gilles Potel; Saralee Bajaksouzian; Joseph D Rutter; Amokrane Reghal; Stuart Shapiro; Magdalena A Taracila; Michael R Jacobs; Robert A Bonomo; Cédric Jacqueline
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

5.  Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Thomas D Gootz; Wenchi Shang; Justin Stroh; William Lau; Dale McLeod; Loren Price; Anthony Marfat; Anne Distler; Sarah M Drawz; Hansong Chen; Emily Harry; Micheal Nottingham; Paul R Carey; John D Buynak; Robert A Bonomo
Journal:  Biochem Pharmacol       Date:  2011-12-02       Impact factor: 5.858

6.  Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.

Authors:  Christopher R Bethel; Magdalena Taracila; Teresa Shyr; Jodi M Thomson; Anne M Distler; Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Krisztina Papp-Wallace; Richard Bonnet; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

7.  Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase.

Authors:  German Bou; Elena Santillana; Anjaneyulu Sheri; Alejandro Beceiro; Jared M Sampson; Matthew Kalp; Christopher R Bethel; Anne M Distler; Sarah M Drawz; Sundar Ram Reddy Pagadala; Focco van den Akker; Robert A Bonomo; Antonio Romero; John D Buynak
Journal:  J Am Chem Soc       Date:  2010-09-29       Impact factor: 15.419

8.  Supramolecular antibiotics: a strategy for conversion of broad-spectrum to narrow-spectrum antibiotics for Staphylococcus aureus.

Authors:  Thameez M Koyasseril-Yehiya; Alam García-Heredia; Francesca Anson; Poornima Rangadurai; M Sloan Siegrist; S Thayumanavan
Journal:  Nanoscale       Date:  2020-10-22       Impact factor: 7.790

Review 9.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase.

Authors:  Monica A Totir; Marion S Helfand; Marianne P Carey; Anjaneyulu Sheri; John D Buynak; Robert A Bonomo; Paul R Carey
Journal:  Biochemistry       Date:  2007-07-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.